Classes of prohibited substances
Prohibited substances fall into the following classes of substances:
C. Anabolic Agents
E. Peptide and glycoprotein hormones and analogues
All substances belonging to the prohibited classes cannot be used even if they are not listed as examples. For this reason, the term “and related substances” is introduced. This term describes drugs that are related to the class by their pharmacological action and/or chemical structure.
This is not an exhaustive list of prohibited substances. Many substances that do not appear on this list are prohibited under the term “and related substances”. All athletes are strongly advised only to take medicines that are prescribed by a medical doctor and to ensure that they contain only drugs that are not prohibited by the IOC Medical Commission or the responsible authorities. Whenever an athlete is required to undergo a doping control it is essential that all medications and drugs taken or administered in the previous three days are declared on the doping control official record.
Amlneptine, amfepramone, amlphenazole, amphetamine, bambuterol, bromantan, caffeine, carphedon, cathine, cocalne, cropropamide, crotethamide ephedrine, etamlvan, etilamphetamine, etilefrine, fencamfamine, fenetylline, fenfluramine, formoterol, heptaminol, methylendloxyamphetamine, mefenorex, mephentermine, mesocarb, methamphetamine, methoxyphenamine, methylephedrine, methylphenidate, nikethamide, norfenfluramine, pentylentetrazol, phendimetrazine, phentermine, phenylpropanolamine, pholedrine, pipradol, prolintane, propyhexedrine, reproterol, salbutamol, salmeterol, seleglline strychnine, terbutaline,
Dextromoramide, diamorphine (heroin), hydrodone, morphine, pentazocine, pethidine,
Androstenedione, bambuterol, boldenone, clenbuterol, clostebol, danazol, dehydrochlormethyitestosterone, dehydroeplandrosterone, (DHEA), dihydrotestosterone, drostanolone, fenoterol, formoterol, fluoxymesterone, formebolone, gestrinone, mesterolone, metandlenone, metenolone, methandriol, methyltestoterone, mibolerone, nandrolone, norethandrolone, oxandrolone, oxymesterone, oxymetholone, reproterol, salbutamol, salmeterol, stanozolol, terbutaline, testosterone, trenbolone,
Acetazolamide, bendroflumethlazide, bumetanide, canrenone, chlortalldone, ethacrynic acid, furosemide, hydrochlorothiazide, indapamide, mannitol, mersalyl, spironolactone, triamterene,
Bromantan, epitestosterone, probenecid
ACTH, erythropoletin (EPO), hCG, hGH,
Acebutolol, alprenolol, atenolol, betaxolol, bisoprolol, bunolol, labetalol, metoprolol, nadolol, oxprenolol, propranolol, sotalol.
Unless otherwise specifically provided for in the IOC medical code, the detected presence of any amount of the substances in classes (a), (b), (c), (d) and (e) in respect of a test conducted in connection with a competition shall constitute a definite case of doping. The quantity of the substance detected is not material to a definite case of doping.
The detected presence of ephedrine, pseudoephedrine, phenylpropanolamine and cathine in respect of a test conducted in connection with a competition shall constitute a prima face case of doping. Irrespective of quantity of substance detected, the person affected shall have the opportunity to rebut the presumption of doping by providing evidence that the substance was present under circumstances which would suggest that doping was neither intended nor result of gross negligence, willful negligence nor imprudence. In all cases, the onus of rebutting the presumption of doping, when the substance has been detected, shall rest with the person affected.
Out-of-Competition testing is directed solely at prohibited substances in classes (c), (d) and (e). The only positive results for purposes of out-of-competition testing and the application of the IOC Medical Code will be in respect of such classes of prohibited substances and pharmacological and physical manipulation (Class 1 b).